RSS-Feed abonnieren
DOI: 10.1055/s-0031-1273207
© Georg Thieme Verlag KG Stuttgart · New York
Langzeitverlauf 10 Jahre nach transpupillarer Thermotherapie (TTT) kleiner, posteriorer maligner Aderhautmelanome
Long-Term Follow-Up 10 Years after Transpupillary Thermotherapy (TTT) for Small, Posterior Located Malignant Melanomas of the ChoroidPublikationsverlauf
Eingegangen: 12.9.2010
Angenommen: 13.9.2010
Publikationsdatum:
11. April 2011 (online)
![](https://www.thieme-connect.de/media/klimo/201104/lookinside/thumbnails/10.1055-s-0031-1273207-1.jpg)
Zusammenfassung
Hintergrund: Auswertung von Langzeitergebnissen der transpupillaren Thermotherapie (TTT) zur Primärbehandlung kleiner maligner Aderhautmelanome. Patienten und Methoden: In einer prospektiven, nicht randomisierten Interventionsstudie wurden 26 Augen mit kleinen posterioren malignen Aderhautmelanomen (zentral des Äquators gelegen mit einer Basis ≤ 12 und Prominenz ≤ 4,5 mm) im Zeitraum 1/1998 bis 10/1999 mit transpupillarer Thermotherapie nach Standardprotokoll behandelt und über mehr als 10 Jahre nachkontrolliert. Ergebnisse: 13 Männer und 13 Frauen wurden mit TTT behandelt (Altersmedian 64 Jahre). Die Tumorausgangsprominenz betrug im Median 2,45 mm (0,8 – 4,5 mm). Die Nachuntersuchung 10 Jahre postoperativ ergab nach im Median 1,4 TTT-Behandlungen eine komplette Tumorregression ohne Rezidiv in 16 / 26 Augen, eine primäre lokale Tumorkontrolle mit späterem Rezidiv in 6 / 26 Augen und fehlende primäre Tumorkontrolle in 4 / 26 Augen. 2 Patienten verstarben im Beobachtungszeitraum tumorbedingt mit Lebermetastasierung. 14 Augen (vorwiegend bei Tumorlage am hinteren Pol und nach mehr als einer TTT-Behandlung) entwickelten okuläre Komplikationen: Makular Pucker in 8, Makulaödem in 6, choroidale Neovaskularisationen in 4 und posteriore Synechien mit Irisatrophie in einem Auge. Schlussfolgerung: Maligne Aderhautmelanome, die mit TTT als alleinigem Therapieverfahren behandelt wurden, zeigen im Langzeitverlauf hohe Raten von lokalen Tumorrezidiven und okulären Komplikationen. Ein enges Monitoring für alle so behandelten Patienten ist daher lebenslang zwingend notwendig.
Abstract
Background: The aim of this study was to evaluate the long-term results of transpupillary thermotherapy (TTT) for small malignant choroidal melanomas. Patients and Methods: In the time period 1/1998 to 10/1999 in a prospective non-randomised analysis 26 eyes with small malignant melanomas (located posterior to the equator with base ≤ 12 and thickness ≤ 4.5 mm) were primary treated with the TTT standard protocol (follow-up over a time span of at least 10 years). Results: Thirteen women and thirteen men (mean age: 64 years) underwent TTT. The mean preoperative tumour thickness was 2.45 mm (0.8 – 4.5 mm). Ten years postoperatively tumour regression without recurrence after 1.4 treatment sessions (mean) was achieved in 16 / 26 eyes, primary regression followed by tumour regrowth in 6 / 26 eyes, and primary failure of tumour regression in 4 / 26 eyes. Two patients died on liver metastasis. Ocular complications (with preference in posterior tumours after multiple TTT sessions) were observed in 14 eyes: macular pucker in 8, macular oedema in 6, choroidal neovascularisation in 4 and posterior synechia with iris atrophy in one eye. Conclusions: Choroidal melanomas treated with TTT as a stand-alone procedure need a close monitoring since these tumours developed a significant rate of local recurrences and ocular side-effects in the long run.
Schlüsselwörter
malignes Aderhautmelanom - transpupillare Thermotherapie - Langzeitverlauf - Tumorrezidive - okuläre Komplikationen
Key words
malignant choroidal melanoma - transpupillary thermotherapy - long-term follow-up - tumour reccurrence - ocular side-effects
Literatur
- 1 Aaberg T M Jr, Bergstrom C S, Hickner Z J et al. Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma. Br J Ophthalmol. 2008; 92 (6) 741-746
- 2 Cruess A F, Augsburger J J, Shields J A et al. Regression of posterior uveal melanomas following cobald-60 plaque radiotherapy. Ophthalmology. 1984; 91 1716-1719
- 3 Currie Z I, Rennie I G, Talbot J F. Retinal vascular changes associated with transpupillary thermotherapy for choroidal melanomas. Retina. 2000; 20 620-626
- 4 Diaz C E, Capone A, Grossniklaus H E. Clinicopathologic findings in recurrent choroidal melanoma after transpupillary thermotherapy. Ophthalmology. 1998; 105 1419-1424
- 5 Finger P T. Radiation Therapy for Choroidal Melanoma. Surv Ophthalmol. 1997; 42 (3) 215-232
- 6 Finger P T, Lipka A C, Lipkowitz J L et al. Failure of transpupillary thermotherapy (TTT) for choroidal melanoma: two cases with histopathological correlation. Br J Ophthalmol. 2000; 84 1075-1076
- 7 Gruterich M, Mueller A J, Ulbig M et al. What is the value of transpupillary thermotherapy in treatment of flat posterior choroid melanomas.A sytematic review of the literature. Klin Monatsbl Augenheilkd. 1999; 215 (3) 147-151
- 8 Harbour J W, Meredith T A, Thompson P A et al. Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology. 2003; 110 (11) 2207-2214
- 9 Journée-Korver J G, Oosterhuis J A, Wolff-Rouendaal de D et al. Histopathological findings in human choroidal melanomas after transpupillary thermotherapy. Br J Ophthalmol. 1997; 81 234-239
- 10 Keunen de J EE, Journée-Korver J G, Oosterhuis J A. Transpupillary thermotherapy of choroidal melanoma with or without brachytherapy: A dilemma. Br J Ophthalmol. 2000; 84 1075-1076
- 11 Langmann de G, Kleinert R, Faulborn J. Transpupillary Diode Laser Hyperthermia – Histopathologic Finding of Eyes with Melanoma and First Clinical Results. Vortrag auf der Jahrestagung der Retinologischen Gesellschaft München; Juni/1996
- 12 Leeper D. Molecular and cellular mechanism of hyperthermia alone or combined with other modalities. In: Overgaard J, ed. Hyperthermic Oncology.. 2 London, England: Taylor & Francis Ltd; 1985: 9-40
- 13 Lommatzsch P K. Results after Beta-irradiation (Ru-106 /Rh-106) of choroidal melanomas: 20 year’s experience. Br J Ophthalmol. 1986; 70 844-851
- 14 MacFaul P A, Morgan G. Histopathological changes in malignant melanoma of the choroid after cobald plaque therapy. Br J Ophthalmol. 1977; 61 221-228
- 15 Nuijs-Beems E M, Oosterhuis J A, Verburg-Marel E H et al. Tumor destruction by intermediate level hyperthermia. Curr Eye Res. 1990; 9 771-780
- 16 Oosterhuis J A, Journée-Korver de H G, Kakebeeke-Kemme H M et al. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol. 1995; 113 315-321
- 17 Oosterhuis J A, Journee-Korver de H G, Keunen J EE. Transpupillary thermotherapy. Results in 50 patients with choroidal melanoma. Arch Ophthalmol. 1998; 116 157-162
- 18 Pan van der Y, Diddie K, Lim J I. Primary transpupillary thermotherapy for small choroidal melanomas. Br J Ophthalmol. 2008; 92 (6) 747-750
- 19 Parrozzani R, Boccassini B, De Belvis V et al. Long-term outcome of transpupillary thermotherapy as primary treatment of selected choroidal melanoma. Acta Ophthalmol. 2008; [Epub ahead of print]
- 20 Pilotto E, Vujosevic S, De Belvis V et al. Long-term choroidal vascular changes after iodine brachytherapy versus transpupillary thermotherapy for choroidal melanoma. Eur J Ophthalmol. 2009; 19 (4) 646-653
- 21 Reinhold H S, Endrich B. Invited review: tumor microcirculation as a target for hyperthermia. Int J Hyperthermia. 1986; 2 111-137
- 22 Robertson D M, Buettner H, Bennett S R. Transpupillary thermotherapy as primary treatment for small choroidal melanomas. Arch Ophthalmol. 1999; 117 1512-1519
- 23 Rotman M, Long R S, Packer S et al. Radiation therapy of choroidal melanoma. Trans Ophthalmol Soc U K. 1977; 97 431-435
- 24 Shields C L, Shields J A, Kiratli H et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 1995; 102 1351-1361
- 25 Shields C L. Clinical evaluation of choroidal tumors. In: Yanuzzi L A, Flower R W, Slakter J S, (eds.) Indocyanine Green Angiography.. St. Louis: Mosby; 1997: 271-295
- 26 Shields C L, Cater J, Shields J A et al. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol. 2000; 118 360-364
- 27 Shields C L, Shields J A, Perez N et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases. Ophthalmology. 2002; 109 225-234
- 28 Shields J A, Augsburger J J, Brady L W et al. Cobald plaque therapy for posterior uveal melanomas. Ophthalmology. 1982; 89 1201-1207
- 29 Singh A D, Kivelä T, Seregard S et al. Primary transpupillary thermotherapy of „small” choroidal melanoma: is it safe ?. Br J Ophthalmol. 2008; 92 (6) 727-728
- 30 Song C W. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984; 44 (Suppl) 4721-4730
- 31 Stoffelns B M, Kutzner J, Schoepfer K et al. Prospective nonrandomized analysis of „sandwich therapy” for malignant melanomas of the choroid. Klin Monatsbl Augenheilkd. 2002; 219 (4) 211-215
- 32 Stoffelns B M. Primary transpupillary thermotherapy (TTT) for malignant choroidal melanoma. Acta Ophthalmol Scand. 2002; 80 (1) 25-31
- 33 Stoffelns B M. Morphologische und funktionelle Ergebnisse nach transpupillarer Thermotherapie (TTT) maligner Aderhautmelanome. Klin Monatsbl Augenheilkd. 2006; 223 74-80
- 34 Win P H, Robertson D M, Buettner H et al. Extended follow-up of small melanocytic choroidal tumors treated with transpupillary thermotherapy. Arch Ophthalmol. 2006; 124 (4) 503-506
- 35 Yarovoy A A, Magaramov D A, Bulgakova E S. Which choroidal melanoma should be treated with primary transpupillary thermotherapy? Our experience from 78 patients. Eur J Ophthalmol. 2010; 20 (1) 186-193
PD Dr. Bernhard Stoffelns
Augenklinik der Universitätsmedizin, Johannes Gutenberg-Universität
Langenbeckstrasse 1
55131 Mainz
Telefon: ++ 49/61 31/1 77 1 33
Fax: ++ 49/61 31/1 76 6 20
eMail: bernhard.stoffelns@unimedizin-mainz.de